Skip to main content
Premium Trial:

Request an Annual Quote

Boehringer Ingelheim Taps IDBS’ E-WorkBook Suite to Support R&D


NEW YORK (GenomeWeb) – IDBS said this week the Boehringer Ingelheim is using IDBS' E-WorkBook Suite to help streamline and improve its research and development efforts.

The pharma firm has deployed the solution in its North American offices with the next roll-out planned for Germany, IDBS said. Eventually, it will be used by 2,400 users globally. The suite will help researchers at Boehringer Ingelheim capture, record, search, retrieve, and share data more efficiently. The E-Workbook will also be integrated with existing infrastructure such as laboratory information management systems to enable a more centralized and highly configurable data flow.

Boehringer Ingelheim selected E-Workbook because, among other reasons, it "enables us to derive value from our data across all of our domains including research, development, and animal health," Thomas Reith, head of IT research & development and medicine at the pharma company, said in a statement. IDBS "exceeded our expectations during the pilot program and we can now retire multiple in-house solutions to support our future growth on a global basis."

The financial terms of the agreement were not disclosed.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.